http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015013709-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17da69d78b9fd9d459b9af39bcf9b604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-12
filingDate 2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f789b76991903670aab625947e687fa
publicationDate 2015-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015013709-A3
titleOfInvention Compositions for treating skin thickening
abstract Compositions and products for treating or reducing skin thickening in a subject are described. Also described are compositions for use in methods of inhibiting a skin disorder induced by an UV- irradiation. The methods involve topically administering to the subject a composition containing an a adrenergic receptor agonist, such as brimonidine.
priorityDate 2013-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004105703-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005115395-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011117378-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011061252-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012001065-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013010032-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244

Total number of triples: 41.